Search research articles
Contact Us
Filters
Showing results (101-110 of 156) with videos related to
Page
of 16
Sort By:
Leukemia & Lymphoma
|
July 9, 2019
Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL)
Flavia Salvi, Stefano Luminari, Alessandra Tucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 8, 2011
First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial
Umberto Vitolo, Annalisa Chiappella, Andrés J M Ferreri, et al.
Blood
|
June 20, 2015
Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma
Luca Ceriani, Maurizio Martelli, Pier Luigi Zinzani, et al.
Bone Marrow Transplantation
|
April 15, 2025
Outcomes of patients with Hodgkin lymphoma receiving Brentuximab Vedotin (BV) as maintenance therapy after ASCT according to previous exposure to BV. A retrospective analysis of the EBMT Lymphoma Working Party in collaboration with GELTAMO, FIL, LYSA, and Turkish Lymphoma Group
Carmen Martínez, Irma Khvedelidze, Mathilde Fekom, et al.
American Journal of Hematology
|
October 5, 2016
Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients
Nicola Polverelli, Massimo Breccia, Giulia Benevolo, et al.
Leukemia & Lymphoma
|
March 8, 2025
A phase 2 study of autologous stem cell transplantation as salvage therapy for older patients with aggressive B-cell lymphoma prospectively evaluated by comprehensive geriatric assessment: the FIL_RECANZ study
Alessandra Tucci, Alessandro Re, Chiara Pagani, et al.
Cancers
|
December 10, 2021
EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3)
Magda Zanelli, Francesca Sanguedolce, Andrea Palicelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2023
Long-Term Follow-Up of the Response-Adapted Intergroup EORTC/LYSA/FIL H10 Trial for Localized Hodgkin Lymphoma
Massimo Federico, Catherine Fortpied, Yana Stepanishyna, et al.
Infection and Immunity
|
March 21, 2022
A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants
Claudio Costantini, Emilia Nunzi, Angelica Spolzino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 3, 2017
Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma
Stefano Luminari, Angela Ferrari, Martina Manni, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 156) with videos related to
Sort By:
Page
of 16
Leukemia & Lymphoma
|
July 9, 2019
Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL)
Flavia Salvi, Stefano Luminari, Alessandra Tucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 8, 2011
First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial
Umberto Vitolo, Annalisa Chiappella, Andrés J M Ferreri, et al.
Blood
|
June 20, 2015
Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma
Luca Ceriani, Maurizio Martelli, Pier Luigi Zinzani, et al.
Bone Marrow Transplantation
|
April 15, 2025
Outcomes of patients with Hodgkin lymphoma receiving Brentuximab Vedotin (BV) as maintenance therapy after ASCT according to previous exposure to BV. A retrospective analysis of the EBMT Lymphoma Working Party in collaboration with GELTAMO, FIL, LYSA, and Turkish Lymphoma Group
Carmen Martínez, Irma Khvedelidze, Mathilde Fekom, et al.
American Journal of Hematology
|
October 5, 2016
Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients
Nicola Polverelli, Massimo Breccia, Giulia Benevolo, et al.
Leukemia & Lymphoma
|
March 8, 2025
A phase 2 study of autologous stem cell transplantation as salvage therapy for older patients with aggressive B-cell lymphoma prospectively evaluated by comprehensive geriatric assessment: the FIL_RECANZ study
Alessandra Tucci, Alessandro Re, Chiara Pagani, et al.
Cancers
|
December 10, 2021
EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3)
Magda Zanelli, Francesca Sanguedolce, Andrea Palicelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2023
Long-Term Follow-Up of the Response-Adapted Intergroup EORTC/LYSA/FIL H10 Trial for Localized Hodgkin Lymphoma
Massimo Federico, Catherine Fortpied, Yana Stepanishyna, et al.
Infection and Immunity
|
March 21, 2022
A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants
Claudio Costantini, Emilia Nunzi, Angelica Spolzino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 3, 2017
Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma
Stefano Luminari, Angela Ferrari, Martina Manni, et al.
Page
of 16